Howard Capital Management’s Eli Lilly LLY Stock Holding History

Howard Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.34M	Sell	4,715 -4,391	-48%	-$4.45M	0.07%	78
2025 Q4	$9.79M	Buy	9,106 +62	+0.7%	+$59.3K	0.13%	51
2025 Q3	$6.9M	Buy	9,044 +244	+3%	+$182K	0.09%	60
2025 Q2	$6.86M	Buy	8,800 +2,194	+33%	+$1.7M	0.1%	53
2025 Q1	$5.46M	Sell	6,606 -924	-12%	-$769K	0.14%	54
2024 Q4	$5.81M	Buy	7,530 +392	+5%	+$325K	0.09%	55
2024 Q3	$6.32M	Buy	+7,138	New	+$6.42M	0.1%	46
2023 Q4	–	Sell	-8,609	Closed	-$4.62M	–	72
2023 Q3	$4.62M	Buy	8,609 +306	+4%	+$158K	0.62%	18
2023 Q2	$3.89M	Buy	8,303 +3,687	+80%	+$1.55M	0.53%	19
2023 Q1	$1.59M	Sell	4,616 -2,423	-34%	-$817K	0.27%	21
2022 Q4	$2.58M	Buy	7,039 +3,995	+131%	+$1.42M	0.73%	10
2022 Q3	$985K	Buy	+3,044	New	+$964K	0.29%	12

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Howard Capital Management's LLY Position: Q1 2026 in Review

Howard Capital Management reduced its Eli Lilly (LLY) stake by 48% in Q1 2026, selling an estimated $4.45M and leaving 4,715 shares worth $4.34M. The position accounts for 0.07% of the portfolio, ranked #78.

Howard Capital Management first reported a position in LLY in Q3 2022 and has held it in 12 quarters since. The position peaked at $9.79M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Howard Capital Management held 4,715 shares of Eli Lilly worth $4.34M as of Q1 2026.
Howard Capital Management sold 4,391 Eli Lilly shares in Q1 2026, an estimated $4.45M.
Eli Lilly made up 0.07% of Howard Capital Management's portfolio in Q1 2026, its #78 holding.
Howard Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 12 quarters since.
Howard Capital Management's Eli Lilly position peaked at $9.79M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Howard Capital Management's 13F filing for Q1 2026, filed 5 May 2026.